In order to further clarify whether Gal-3BP was account for the IL6 inhibition effect of LPC activated by NQO1, two siRNAs targeting Gal-3BP with different sequences were transfected into NB cells in the presence or absence of dicoumarin, and then the IL6 secretion from iBMSC was detected. The gene discussed is IL6; the disease is neuroblastoma.